AR legalization initiative snag; CA psychedelics & marijuana bills teed up; IL cannabis sales jump; Study: Legalization boosts college applications

Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.

Your support makes Marijuana Moment possible…

Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen.

If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment


The National Conference of State Legislatures adopted a resolution calling for federal marijuana legalization and urging Congress to pass cannabis banking legislation.

The Arkansas Board of Election Commissioners declined to certify the ballot title and popular name of a marijuana legalization initiative even after the secretary of state verified that activists collected enough signatures. The dispute is expected to end up before the state Supreme Court.

The California Assembly Appropriations Committee teed up Senate-passed bills to legalize psychedelics possession, authorize interstate marijuana agreements and mandate that localities allow medical cannabis delivery for a crucial legislative hurdle next week.

The Illinois Department of Finance and Professional Regulation reported that retailers sold more than $135 million worth of adult-use marijuana products in July—the second biggest month ever. It also saw the largest number of individual cannabis products sold.

A new study found that colleges in states with legal marijuana see a significant boost in student applications—but that the effect has diminished over time as more states enact legalization and students have more options for cannabis-friendly jurisdictions across the country.


The U.S. Department of Agriculture published a short podcast on challenges in the growing hemp industry.

Rep. Troy Carter (D-LA) spoke about his new marijuana expungements bill.


Arkansas Democratic gubernatorial candidate Chris Jones said he supports a ballot initiative to legalize marijuana.

California Republican senators are urging Gov. Gavin Newsom (D) to veto a bill to legalize safe consumption sites for illegal drugs.

New Jersey Republican lawmakers are highlighting a study on the purported harms of high-potency marijuana.

New Mexico’s former top marijuana regulator is now working for a cannabis consulting firm called Weeds.

Washington State regulators proposed changes to marijuana social equity rules.

Vermont regulators opened applications for marijuana retail licenses four weeks earlier than expected.

New York regulators published a summary of public comments about proposed marijuana dispensary rules, along with their responses.

Colorado regulators are launching a hemp networking directory.

Nevada regulators are facing complaints from marijuana businesses that say they are being sent excessive hourly bills from state officials.

Michigan regulators released a form that consumers can use to report adverse reactions to cannabis products.

Iowa regulators published a data report on the medical cannabidiol program.

Marijuana Moment is tracking more than 1,500 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.


The Athens-Clarke County, Georgia Commission approved a marijuana decriminalization ordinance.

The San Marcos, Texas City Council placed a marijuana decriminalization initiative on the November ballot rather than immediately enact the reform.


Australian Capital Territory lawmakers are considering legislation to lower penalties for drug possession.

A survey found that British Columbia, Canada residents are using more cannabis than in the past, but are likely to purchase it from licensed retailers.


A study concluded that “medical marijuana has an important role in the palliation of symptoms in advanced cancers with few adverse effects.”

A study concluded that “CBD is safe and effective in reducing pain in the immediate peri-operative period following [arthroscopic rotator cuff repair] and should be considered in post-operative multimodal pain control.”


The Sacramento Bee editorial board is calling on California lawmakers to pass a bill to legalize possession of psychedelics.

The Boston Herald editorial board is criticizing legislation passed by lawmakers that would require regulators to study the possibility of allowing medical cannabis to be administered to students at schools.


Green Thumb Industries Inc.  reported quarterly revenue of $254.3 million.

New Mexico health insurance companies that are being sued over lack of coverage for medical cannabis succeeded in moving the case to federal court.

The Scotts Miracle-Gro Company reported that sales for its cannabis-focused Hawthorne unit decreased 63 percent in the most recent quarter.

NewLake Capital Partners, Inc. added two lenders to an existing revolving credit facility and upsized the aggregate commitment from $30 million to $90 million.


Basketball player Iman Shumpert was arrested for having a “sizable” amount of marijuana at an airport.

Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.


Source link

Medical Disclaimer:

The information provided in these blog posts is intended for general informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. The use of any information provided in these blog posts is solely at your own risk. The authors and the website do not recommend or endorse any specific products, treatments, or procedures mentioned. Reliance on any information in these blog posts is solely at your own discretion.

Leave a Reply
You May Also Like